Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
p53 Mutations in Human Cancers
1991 • 8,133 citations
p53, the Cellular Gatekeeper for Growth and Division
1997 • 7,621 citations
Surfing the p53 network
2000 • 6,487 citations
p53: puzzle and paradigm.
1996 • 2,363 citations
S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles
2001 • 1,555 citations
p53 Status and the Efficacy of Cancer Therapy in Vivo
1994 • 1,483 citations
A gene expression database for the molecular pharmacology of cancer
2000 • 1,447 citations
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
1997 • 1,177 citations
Disruption of p53 in human cancer cells alters the responses to therapeutic agents
1999 • 1,044 citations
Heat-shock protein 70 antagonizes apoptosis-inducing factor
2001 • 846 citations
NPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcription
2000 • 650 citations
Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
2000 • 643 citations
Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme
1998 • 537 citations
Wild-type p53 can down-modulate the activity of various promoters.
1991 • 461 citations
Identification and classification of p53-regulated genes
1999 • 460 citations
AP-1: One Switch for Many Signals
1999 • 386 citations
Phosphorylation of Bid by Casein Kinases I and II Regulates Its Cleavage by Caspase 8
2001 • 341 citations
DNA microarrays identification of primary and secondary target genes regulated by p53
2001 • 332 citations
Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
1992 • 328 citations
Endoglin modulates cellular responses to TGF-beta 1.
1996 • 306 citations
Tumor Suppressor p53 Protein Is a New Target for the Metastasis-associated Mts1/S100A4 Protein
2001 • 282 citations
Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function.
1997 • 241 citations
CD105 antagonizes the inhibitory signaling of transforming growth factor βl on human vascular endothelial cells
2000 • 232 citations
Topotecan – A Novel Topoisomerase I Inhibitor: Pharmacology and Clinical Experience
1999 • 199 citations
Regulation of p53 stability and activity in response to genotoxic stress
2000 • 186 citations
Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches
2001 • 166 citations
Metastasis-associated Mts1 (S100A4) Protein Modulates Protein Kinase C Phosphorylation of the Heavy Chain of Nonmuscle Myosin
1998 • 130 citations
Liprin β1, a Member of the Family of LAR Transmembrane Tyrosine Phosphatase-interacting Proteins, Is a New Target for the Metastasis-associated Protein S100A4 (Mts1)
2002 • 124 citations
p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells
2001 • 111 citations
Calcium and S100B Regulation of p53-Dependent Cell Growth Arrest and Apoptosis
1998 • 104 citations
S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis.
1998 • 104 citations
Development of a prostate cDNA microarray and statistical gene expression analysis package
2000 • 100 citations
Effect of reduced myristoylated alanine-rich C kinase substrate expression on hippocampal mossy fiber development and spatial learning in mutant mice: Transgenic rescue and interactions with gene background
1998 • 66 citations
The ARG Tyrosine Kinase Interacts with Siva-1 in the Apoptotic Response to Oxidative Stress
2001 • 66 citations
Calmodulin and Cyclin D Anchoring Sites on the Src-Suppressed C Kinase Substrate, SSeCKS
2002 • 52 citations
Cited By (0)
No citing papers found in database